Clinical Trial Update: Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

View source ↗

Summary

A clinical trial evaluating allergic reactions to Benefix (nonacog alfa) in Hemophilia B patients has completed. The sponsor Wyeth is now a wholly owned subsidi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BeneFIX (recombinant coagulation factor IX concentrate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Hemophilia B | Status: COMPLETED